Nonsurgical creation of a pericardial window using the inoue balloon catheter

Chow, Wing‐Hing; Chow, Tsun‐Cheung; Cheung, King‐Loong

doi:10.1016/0002-8703(92)91006-m

Cited by 19 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9,15 There is a small experience with control of pericardial window using percutaneous balloon dilation techniques. 16 Surgical creation of a pericardial window is usually successful in the permanent control of the pericardial effusive process. In those who were discharged from the hospital in this study, 95% remained free of recurrence and were successfully palliated by the creation of a surgical pericardial window.…”

Section: Discussionmentioning

confidence: 99%

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy

Cullinane

Paz

Smith

et al. 2004

Chest

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy

Cullinane

Paz

Smith

et al. 2004

Chest

View full text Add to dashboard Cite

“…All these techniques carry a significant risk of morbidity (10-67%) and mortality [5,6]. Since 1991, several reports have demonstrated the feasibility and safety of percutaneous balloon pericardiotomy [ 1, 4,7,8]. It appears that immediate and long-term results are quite similar to subxyphoid surgical windowing, without the drawbacks of the surgery [3].…”

Section: Discussionmentioning

confidence: 99%

Percutaneous balloon pericardiotomy: A case report and analysis of mechanism of action

Bertrand

Legrand

Kulbertus

1996

Cathet. Cardiovasc. Diagn.

View full text Add to dashboard Cite

A 33‐year‐old man with acquired immunodeficiency syndrome (AIDS) and cardiac tamponade underwent percutaneous balloon pericardiotomy. To elucidate the pathway of fluid elimination, at the end of the procedure, we injected methylene blue into the pericardial space. Contrary to previous belief, we found no blue discoloration of the pleural fluids, and thus we postulate that most of the fluid was eliminated by peritoneal resorption. © 1996 Wiley‐Liss, Inc.

show abstract

“…Chest radiography should be performed to monitor for the development of pleural effusion caused by drainage of the pericardial fluid. Technical variations in the subxiphoid technique of percutaneous balloon pericardial window creation include the dilation of two adjacent pericardial sites, the use of the apical approach, the use of an Inoue (Toray Medical Group, Houston, TX) balloon catheter, the use of double balloons, and the use of an 18-mm dilating balloon to facilitate the introduction of a 16 F chest tube into the pericardial space [35][36][37][38]. Other investigators have attempted laparoscopic pericardial fenestration [39,40].…”

Section: Percutaneous Balloon Pericardial Window Creationmentioning

confidence: 99%

Pericardial effusion and tamponade

Palacios

1999

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Pericardial effusion may occur as a result of a variety of clinical conditions, including viral, bacterial, or fungal infections and inflammatory, postinflammatory, autoreactive, and neoplastic processes. More common causes of pericardial effusion and tamponade include malignancy, renal failure, viral and bacterial infectious processes, radiation, aortic dissection, and hypothyroidism. It can also occur after trauma or acute myocardial infarction (as in postpericardiotomy syndrome following cardiac or thoracic surgery) or as an idiopathic pericardial effusion. Although pericardial effusion is common in patients with connective tissue disease, cardiac tamponade is rare. Among medical patients, malignant disease is the most common cause of pericardial effusion with tamponade. Table 1 shows the causes of pericardial tamponade. The effusion fluid may be serous, suppurative, hemorrhagic, or serosanguineous. The pericardial fluid can be a transudate (typically occurring in patients with congestive heart failure) or an exudate. The latter type, which contains a high concentration of proteins and fibrin, can occur with any type of pericarditis, severe infections, or malignancy. Once the diagnosis of pericardial effusion has been made, it is important to determine whether the effusion is creating significant hemodynamic compromise. Asymptomatic patients without hemodynamic compromise, even with large pericardial effusions, do not need to be treated with pericardiocentesis unless there is a need for fluid analysis for diagnostic purposes (eg, in acute bacterial pericarditis, tuberculosis, and neoplasias). The diagnosis of pericardial effusion/tamponade relies on a strong clinical suspicion and is confirmed by echocardiography or other pericardial imaging modalities. Alternatively, when the diagnosis of cardiac tamponade is made, there is a need for emergency drainage of pericardial fluid by pericardiocentesis or surgery to relieve the hemodynamic compromise. Following pericardiocentesis, it is necessary to prevent recurrence of tamponade. Intrapericardial injection of sclerosing agents, surgical pericardiotomy, and percutaneous balloon pericardial window creation are techniques used to prevent reaccumulation of pericardial fluid and recurrence of cardiac tamponade.

show abstract

Nonsurgical creation of a pericardial window using the inoue balloon catheter

Cited by 19 publications

References 3 publications

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy

Percutaneous balloon pericardiotomy: A case report and analysis of mechanism of action

Pericardial effusion and tamponade

Contact Info

Product

Resources

About